Simultaneous assay of buprenorphine and norbuprenorphine by negative chemical ionization tandem mass spectrometry

Journal of Analytical Toxicology

Volumn 20, Issue 4, 1996, Pages 229-235

  Kuhlman Jr , James J ^a   Magluilo Jr , Joseph ^a   Cone, Edward ^b   Levine, Barry ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; DRUG METABOLITE;

ADULT; ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ISOLATION; HUMAN; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; QUANTITATIVE ASSAY; SOLID PHASE EXTRACTION; SUBCUTANEOUS DRUG ADMINISTRATION; TANDEM MASS SPECTROMETRY;

EID: 0029950508     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/20.4.229     Document Type: Article

References (20)

1. th ed., Facts and Comparisons, St. Louis, MO, 1994, pp 1181-82.
2. G.E. Bigelow and K.L. Preston. In Buprenorphine: An Alternative Treatment for Opioid Dependence, Assessment of Buprenorphine in a Drug Discrimination Procedure in Humans. National Institute on Drug Abuse Research Monograph 121, U.S. Department of Health and Human Services, Rockville, MD, 1992, pp 28-37.
3. S.S. Negus, M.J. Picker, and L.A. Dykstra. Kappa antagonist properties of buprenorphine in non-tolerant and morphine-tolerant rats. Psychopharmacology 98: 141-49 (1989).
4. J.W. Lewis. Buprenorphine. Drug and Alcohol Dependence 14: 363-72 (1985).
5. R.E.S. Bullingham, H.J. McQuay, A. Moore, and M.R.D. Bennett. Buprenorphine kinetics. Clin Pharmacol Ther. 28: 667-72 (1980).
6. N.K. Mello and J.H. Mendelson. Buprenorphine suppresses heroin use by heroin addicts. Science 207: 657-59 (1980).
7. J.H. Mendelson and N.K. Mello. In Buprenorphine: An Alternative Treatment for Opioid Dependence, Assessment of Buprenorphine in a Drug Discrimination Procedure in Humans, National Institute on Drug Abuse Research Monograph 121, U.S. Department of Health and Human Services, Rockville, MD, 1992, pp 38-60.
8. C.W. Hand, K.E. Ryan, S.K. Dutt, R.A. Moore, J. O'Connor, D. Talbot, and H.J. McQuay. Radioimmunoassay of buprenorphine in urine: studies in patients and in a drug clinic. J. Anal. Toxicol. 13: 100-104 (1989).
9. 63Ni electron capture gas chromatographic assay for buprenorphine and metabolites in human urine and feces. J. Chromatogr. 337: 291-300 (1985).
10. Y. Blom and U. Bondesson. Analysis of buprenorphine and its N-dealkylated metabolite in plasma and urine by selected ion monitoring. J. Chromatogr. 338: 89-98 (1985).
11. M. Ohtani, F. Shibuya, H. Kotahi, K Uchino, Y. Saitoh, and F. Nakagawa. Quantitative determination of buprenorphine and its metabolite, norbuprenorphine, in human plasma by gas chromatography-chemical ionization mass spectrometry. J. Chromatogr. 487: 469-75 (1989).
12. D. Martinez, M.C. Jurado, and M. Repetto. Analysis of buprenorphine in plasma and urine by gas chromatography. J. Chromatogr. 528: 459-63 (1990).
13. L.P. Hackett, L.J. Dusci, and K.F. Ilett. Sensitive screening method for buprenorphine in urine. J. Chromatogr. 374: 400-404 (1986).
14. L. Debrabandere, M. Van Boven, and P Daenens. Analysis of buprenorphine in urine specimens. J. Forensic Sci. 37: 82-89 (1992).
15. E. Schleyer, R. Lohmann, C. Rolf, A. Cralow, C.C. Kaufmann, M. Unterhalt, and W. Hiddemann. Column-switching solid-phase trace-enrichment high performance liquid chromatographic method for measurement of buprenorphine and norbuprenorphine in human plasma and urine by electrochemical detection. J. Chromatogr. 614: 275-78 (1993).
16. P. Kintz, V. Cirimele, E. Yves, C. Jamey, and P. Mangin. Hair analysis for buprenorphine and its dealkylated metabolite by RIA and confirmation by LC/ECD. J. Forensic Sci. 39: 1497-1503 (1994).
17. A.J. Bartlett, J.G. Lloyd-Jones, M.J. Rance, I.R. Flockhart, G. Dockray, M.R.D. Bennett, and R.A. Moore. The radioimmunoassay of buprenorphine. Eur. J. Clin. Pharmacol. 18: 339-45 (1980).
18. R.E.S. Bullingham, H.J. McQuay, E.J.B. Porter, M.C. Allen, and M.C. Moore. Sublingual buprenorphine used post operatively: ten hour plasma drug concentration analysis. Br. J. Clin. Pharmacol. 13: 665-73 (1982).
19. R.E.S. Bullingham, H.J. McQuay, and R.A. Moore. Clinical pharmacokinetics of narcotic agonist-antagonist drugs. Clin. Pharmacokinet. 8: 332-43 (1983).
20. TSQ 700 Operation Lecture Manual, Finnigan MAT Institute, Cincinnati, OH, May 1993, p 7.